| Product Name | Abiraterone Ethyl Ether;AB-IMP-12 | 
|---|---|
| CAS | 2484719-14-2 | 
| Formula | C26H35NO | 
| MW | 377.56 | 
| Appearance | White to off-white solid | 
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | 
|---|---|---|---|---|
| 2 mg | In-stock | ¥886.00 | Visible after login | |
| 5 mg | In-stock | ¥1536.00 | Visible after login | |
| 10 mg | In-stock | ¥2616.00 | Visible after login | |
| 20 mg | In-stock | ¥4436.00 | Visible after login | 
| Product Name | Abiraterone Ethyl Ether;AB-IMP-12 | 
|---|---|
| CAS | 2484719-14-2 | 
| Formula | C26H35NO | 
| MW | 377.56 | 
| Appearance | White to off-white solid | 
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
Abiraterone Ethyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17, 20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.